Inhibition of NF-IL6 Activity by Manassantin B, a Dilignan Isolated from Saururus chinensis, in Phorbol Myristate Acetate-stimulated U937 Promonocytic Cells

  • Son, Kyung-No (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University) ;
  • Song, In-Sung (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University) ;
  • Shin, Yong-Hyun (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University) ;
  • Pai, Tong-Kun (Department of Food and Nutrition, Anyang University) ;
  • Chung, Dae-Kyun (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University) ;
  • Baek, Nam-In (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University) ;
  • Lee, Jung Joon (Anticancer Research Laboratory, Korea Research Institute of Bioscience and Biotechnology) ;
  • Kim, Jiyoung (Graduate School of Biotechnology and Institute of Life Sciences and Resources, Kyung Hee University)
  • Received : 2005.03.03
  • Accepted : 2005.05.24
  • Published : 2005.08.31


Mannasantin B, a dilignan structurally related to manssantin A, is an inhibitor of NF-${\kappa}B$ transactivation. In the present study, we found that it inhibited PMA-induced expression of IL-$1{\beta}$, IL-$1{\beta}$ mRNA, and IL-$1{\beta}$ promoter activity in U937 cells with $IC_{50}$ values of about 50 nM. It also inhibited NF-IL6- and NF-${\kappa}B$-induced activation of IL-$1{\beta}$, with $IC_{50}$ values of 78 nM and $1.6{\mu}M$, respectively, revealing a potent inhibitory effect on NF-IL6. Electrophoretic mobility shift assays showed that manassantin B had an inhibitory effect on DNA binding by NF-IL6, but not by NF-${\kappa}B$. Further analysis revealed that transactivation by NF-IL6 was also inhibited. Our results indicate that manassantin B suppresses expression of IL-$1{\beta}$ in promonocytic cells by inhibiting not only NF-${\kappa}B$ but also NF-IL6 activity. Furthermore, our observations suggest that manassantin B may be clinically useful as a potent inhibitor of NF-IL6 activity.


$C/EBP{\beta}$;Inhibitors;Manassantin;NF-${\kappa}B$;NF-IL6;Saururus chinensis


Supported by : Korean Ministry of Agriculture


  1. Braddock, M. and Quinn, A. (2004) Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3, 330-340
  2. De Bosscher, K., Berghe, W. V., and Haegeman, G. (2003) The interplay between the glucocorticoid receptor and nuclear factor-${\kappa}B$ or activator protein-1: molecular mechanisms for gene repression. Endocrine Rev. 24, 488-522
  3. Dinarello, C. A. (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr. Opin. Pharm. 4, 378-385
  4. Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., et al. (1999) Inhibition of interleukin-1-stimulated NFkappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity. J. Biol. Chem. 274, 26448-26453
  5. Henderson, A. J., Zou, X., and Calame, K. (1995) C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J. Virol. 69, 5337-5344
  6. Hwang, B. Y., Lee, J. H., Nam, J. B., Hong, Y. S., and Lee, J. J. (2003a) Lignans from Saururus chinensis inhibiting the transcription factor NF-kappaB. Phytochemistry 64, 765-771
  7. Hwang, B. Y., Lee, J. H., Jung, H. S., Kim, K. S., Nam, J. B., et al. (2003b) Sauchinone, a lignan from Saururus chinensis, suppresses iNOS expression through the inhibition of transactivation activity of RelA of NF-kappaB. Planta Med. 69, 1096-1101
  8. Li, Q. and Verma, I. M. (2002) NF-$I{\kappa}B$ regulation in the immune system. Nat. Rev. Immunol. 2, 725-734
  9. Natsuka, S., Akira, S., Nishio, Y., Hashimoto, S., Sugita, T., et al. (1992) Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 79, 460-466
  10. Pope, R. M., Leutz, M. A., and Ness, S. A. (1994) $C/EBP{\beta}$ regulation of the tumor necrosis factor a gene. J. Clin. Invest. 94, 1449-1455
  11. Saunders, M. A., Sansores-Garcia, L., Gilroy, D. W., and Wu, K. K. (2001) Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J. Biol. Chem. 276, 18897-18904
  12. Son, K. N., Park, J., Chung, C. K., Chung, D. K., Yu, D. Y., et al. (2002) Human lactoferrin activates transcription of $IL-1{\beta}$ gene in mammalian cells. Biochem. Biophys. Res. Commun. 290, 236-241
  13. Tsukada, J., Saito, K., Waterman, W. R., Webb, A. C., and Auron, P. E. (1994) Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin $1{\beta}$ gene. Mol. Cell. Biol. 14, 7285-7297
  14. Vermeulen, L., De Wilde, G., Notebaert, S., Vanden Berghe, W., and Haegeman, G. (2002) Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem. Pharmacol. 64, 963-970
  15. Wegner, M., Cao, Z., and Rosenfeld, M. G. (1992) Calciumregulated phosphorylation within the leucine zipper of C/EBP beta. Science 256, 370-373
  16. Zhang, Y. and Rom, W. N. (1993) Regulation of the Interleukin- $1{\beta}$ gene by Mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol. Cell. Biol. 13, 3831-3837
  17. Nakajima, T., Fukamizu, A., Takahashi, J., Gage, F. H., Fisher, T., et al. (1996) The signal-dependent coactivator CBP is a nuclear target for $pp90^{RSK}$. Cell 86, 465-474
  18. Goto, M., Katayama, K. I., Shirakawa, F., and Tanaka, I. (1998) Involvement of $NF-{\kappa}B$ p50/p65 heterodimer in activation of the human pro-interleukin-$1{\beta}$ gene at two subregions of the upstream enhancer element. Cytokine 11, 16-28
  19. Ramji, D. P. and Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575
  20. Cieslik, K. A., Zhu, Y., Shtivelband, M., and Wu, K. K. (2005) Inhibition of p90 ribosomal S6 kinase-mediated CCAAT/ enhancer-binding protein ${\beta}$ activation and cyclooxygenase-2 expression by salicylate. J. Biol. Chem. 280, 18411-18417
  21. Kunsch, C., Lang, R. K., Rosen, C. A., and Shannon, M. F. (1994) Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6. J. Immunol. 153, 153-164
  22. Buck, M., Poli, V., van der Geer, P., Chojkier, M., and Hunter, T. (1999) Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol. Cell 4, 1087-1092
  23. Roebuck, K. A., Rahman, A., Lakshminarayanan, V., Janakidevi, K., and Malik, A. B. (1995) $H_{2}O_{2}$ and tumor necrosis factoralpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270, 18966- 18974
  24. Zhang, F., Lin, M., Abidi, P., Thiel, G., and Liu, J. (2003) Specific interaction of Egr1 and c/EBP$\beta$ leads to the transcriptional activation of the human low density lipoprotein receptor gene. J. Biol. Chem. 278, 44246-44254
  25. Shirakawa, F., Saito, K., Bonagura, C. A., Galson, D. L., Fenton, M. J., et al. (1993) The human prointerleukin $1{\beta}$gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol. Cell. Biol. 13, 1332-1344
  26. Rho, M. C., Kwon, O. E., Kim, K., Lee, S. W., Chung, M. Y., et al. (2003) Inhibitory effects of manassantin A and B isolated from the roots of Saururus chinensis on PMA-induced ICAM-1 expression. Planta Med. 69, 1147-1149
  27. Akira, S., Isshiki, I., Sugiita, T., Tanabe, O., Kinoshita, S., et al. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906
  28. Akira, S. (1997) IL-6-regulated transcription factors. Int. J. Biochem. Cell Biol. 29, 1401-1418
  29. Lee, S. J., Bai, S. K., Lee, K. S., Namkoong, S., Na, H. J., et al. (2003a) Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing $I{\kappa}B$ kinasedependent NF-$I{\kappa}B$ activation. Mol. Cells 16, 97-105
  30. Schouten, G. J., Vertegaal, A. C., Whiteside, S. T., Israel, A., Toebes, M., et al. (1997) $I{\kappa}B{\alpha}$ is a target for the mitogenactivated 90 kDa ribosomal S6 kinase. EMBO J. 16, 3133- 3144
  31. Catron, K. M., Brickwood, J. R., Shang, C., Li, Y., Shannon, M. F., et al. (1998) Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter. Cell Growth Differ. 9, 949-959
  32. Dunn, S. M., Coles, L. S., Lang, R. K., Gerondakis, S., Vadas, M. A., et al. (1994) Requirement for nuclear factor (NF)- kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony- stimulating factor promoter. Blood 83, 2469-2479
  33. Ghoda, L., Lin, X., and Greene, W. C. (1997) The 90-kDa ribosomal S6 kinase ($pp90^{rsk}^$) phosphorylates the N-terminal regulatory domain of $I{\kappa}B{\alpha}$ and stimulates its degradation in vitro. J. Biol. Chem. 272, 21281-21288
  34. Trautwein, C., Caelles, C., van der Geer, P., Hunter, T., Karin, M., et al. (1993) Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364, 544-547
  35. Henderson, A. J., Connor, R. I., and Calame, K. L. (1996) C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity 5, 91-101
  36. Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., et al. (1993) Phosphorylation at threonine-235 by a rasdependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 90, 2207-2211
  37. Yang, Z., Wara-Aswapati, N., Chen, C., Tsukada, J., and Auron, P. E. (2000) NF-IL6 (C/EBPbeta) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. J. Biol. Chem. 275, 21272-21277
  38. Zhong, H., May, M. J., Jimi, E., and Ghosh, S. (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625- 636
  39. Lee, J. H., Hwang, B. Y., Kim, K. S., Nam, J. B., Hong, Y. S., et al. (2003b) Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis. Biochem. Pharmacol. 66, 1925-1933
  40. Matsusaka, T., Fujikawa, K., Nishio, Y., Mukaida, N., Matsushima, K., et al. (1993) Transcription factors NF-IL6 and NF-kappaB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90, 10193-10197
  41. Stein, B., Cogwell, P. C., and Baldwin Jr, A. S. (1993) Functional and physical associations between NF-kappaB and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13, 3964-3974
  42. Yamamoto, K., Arakawa, T., Ueda, N., and Yamamoto, S. (1995) Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha- dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315-31320